These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5820070)

  • 1. [Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator].
    Takemoto J
    Kumamoto Igakkai Zasshi; 1969 Apr; 43(4):332-59. PubMed ID: 5820070
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially on tissue activator. I. Biochemical study on tissue activator of the uterus.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Apr; 16(2):86-91. PubMed ID: 5819402
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially on tissue activator. II. Localization of tissue activator in the uterus.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Apr; 16(2):92-6. PubMed ID: 5819403
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 3. Tissue activator of the pathologic uterus.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):133-6. PubMed ID: 5394309
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent].
    Rueda F; Félez J
    Sangre (Barc); 1984; 29(4-A):429-48. PubMed ID: 6390755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tissue plasminogen activator].
    Matsuo O
    Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney tissue activator of fibrinolysis in relation to pregnancy.
    Epstein MD; Beller FK; Douglas GW
    Obstet Gynecol; 1968 Oct; 32(4):494-504. PubMed ID: 4193253
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR; Collen D
    Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA; Collen D
    Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.